For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Despite high standards of medical care and the rapid rise of anti-fibrotic therapies, the mortality rates for idiopathic pulmonary fibrosis are still rising. Cong Lin’s research focuses on coagulation factors and their receptors, known as PARs, investigating whether PAR inhibition could be used as an effective therapeutic intervention for fibrotic disorders.

Event details of Treatment of idiopathic pulmonary fibrosis
Date 15 September 2015
Time 14:00 -15:00
Location Agnietenkapel
Room Location

C. Lin: Potential Novel Targets: Protease-Activated Receptors in Idiopathic Pulmonary Fibrosis.


Prof. T. van der Poll


Dr C.A. Spek

Dr K.S. Borensztajn


Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.